Myxothiazol, a new inhibitor of the cytochrome b-c1 segment of the respiratory chain

https://doi.org/10.1016/0005-2728(81)90238-3Get rights and content

Abstract

Myxothiazol inhibited oxygen consumption of beef heart mitochondria in the presence and absence of 2,4-dinitrophenol, as well as NADH oxidation by submitochondrial particles. The doses required for 50% inhibition were 0.58 mol myxothiazol/mol cytochrome b for oxygen consumption of beef heart mitochondria, and 0.45 mol/mol cytochrome b for NADH oxidation by submitochondrial particles. Difference spectra with beef heart mitochondria and with cell suspensions of Saccharomyces cerevisiae revealed that myxothiazol blocked the electron transport within the cytochrome b-c1 segment of the respiratory chain. Myxothiazol induced a spectral change in cytochrome b which was different from and independent of the shift induced by antimycin. Myxothiazol did not give the extra reduction of cytochrome b typical for antimycin. Studies on the effect of mixtures of myxothiazol and antimycin on the inhibition of NADH oxidation indicated that the binding sites of the two inhibitors are not identical.

References (23)

  • G.F. Azzone et al.

    Methods Enzymol.

    (1979)
  • R.W. Estabrook

    Methods Enzymol.

    (1967)
  • A.L. Smith

    Methods Enzymol.

    (1967)
  • D. Ziegler et al.

    Methods Enzymol.

    (1967)
  • J. Šubík et al.

    Biochim. Biophys. Acta

    (1974)
  • U.K. Moser et al.

    FEBS Lett.

    (1975)
  • J.A. Berden et al.

    Biochim. Biophys. Acta

    (1970)
  • J.A. Berden et al.

    Biochim. Biophys. Acta

    (1972)
  • J.S. Rieske

    Biochim. Biophys. Acta

    (1976)
  • W.F. Becker et al.

    Hoppe-Seyler's Z. Physiol. Chem.

    (1980)
  • K. Gerth et al.

    J. Antibiot.

    (1980)
  • Cited by (208)

    • Prediction of drug-induced mitochondrial dysfunction using succinate-cytochrome c reductase activity, QSAR and molecular docking

      2023, Toxicology
      Citation Excerpt :

      In drug discovery, techniques like QSAR, molecular docking and toxicophore models have been successfully used to predict cytotoxicity and specific organ toxicities (Ford et al., 2017; Singh et al., 2016; Frid and Matthews, 2010; Beck et al., 2015). These predictive methods have increasingly become a key part of the AOP approach, which emerged to establish a mechanistic link between an upstream molecular initiating event (MIE) and a downstream adverse effect through a series of events (Ankley et al., 2010; Vinken, 2013; Landesmann et al., 2013). Of paramount importance in AOPs, and in the predictive toxicology discipline in general, is the various aspects of mitochondrial toxicity.

    View all citing articles on Scopus

    Part of this work has been presented at the 33rd conference of the Gesellschaft für Biologische Chemie in Reisensburg, September 19–21, 190 [1].

    View full text